Early results from a phase II randomized trial testing stereotactic body radiation therapy in patients with oligometastatic castration resistant prostate cancer undergoing I line treatment with abiraterone acetate (ARTO trial-NCT03449719)

• G. Francolini,
• P. Garlatti,
• B. Detti,
• A. Bruni,
• G. Mantini,
• S. Pergolizzi,
• P. Borghetti,
• R.M. D’Angelillo,
• F. Alongi,
• B.A. Jereczek-Fossa,
• C. Franzese,
• A. Tagliagambe,
• V. Di Cataldo,
• M. Aquilano,
• M. Mariotti,
• V. Salvestrini,
• L. Ciccone,
• G. Stocchi,
• L. Livi

Affiliations

G. Francolini

P. Garlatti

B. Detti

A. Bruni

G. Mantini

S. Pergolizzi

P. Borghetti

R.M. D’Angelillo

F. Alongi

B.A. Jereczek-Fossa

C. Franzese

A. Tagliagambe

V. Di Cataldo

M. Aquilano

M. Mariotti

V. Salvestrini

L. Ciccone

G. Stocchi

L. Livi